NOVATO, Calif., July 12, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today announced that it has appointed Howard Horn as executive vice president and chief financial officer (CFO) effective October 16,…Read More
Ultragenyx Pharmaceutical Inc Ultragenyx Appoints Howard Horn as Chief Financial Officer and Executive Vice President Corporate Strategy
